Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-17-000041

Options or other derivatives

  • Senior Vice President acquired 21,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ocain Tim · Senior Vice President

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-11-17 Grant or award : show line 1 in the form Stock Option (right to buy) +21,500 $48.52 2027-11-17 21,500 21,500 D
Loading xslF345X03/edgar.xml…